Working... Menu
Trial record 4 of 11 for:    placenta malaria

Safety and Immunogenicity of the Placental Malaria Vaccine Candidate PAMVAC Variously Adjuvanted (PAMVAC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02647489
Recruitment Status : Completed
First Posted : January 6, 2016
Last Update Posted : June 25, 2018
University of Copenhagen
Université d'Abomey-Calavi
European Malaria Vaccine Initiative
Institut de Recherche pour le Developpement
Expres2ion Biotechnologies APS
Information provided by (Responsible Party):
University Hospital Tuebingen

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : November 10, 2017
  Actual Study Completion Date : November 10, 2017